Bioluminescence Ventures

Bioluminescence Ventures is a biotechnology venture firm investing in the future of medicine. The firm focuses its investments on Drug Discovery Platforms, Applied Biology Platforms, and Computational Biology Platforms. The firm has offices in San Francisco (HQ) and Cambridge.

Biomedical research is entering a Golden Age of Discovery – industrialized by hardware / software technologies, powered by longitudinal multi-modal data sets, and translated into novel therapeutic approaches by a new generation of multidisciplinary founders. Bioluminescence was conceptualized and launched to potentiate this next generation of translational founders. Patient impact is our guiding light, and we see this light radiating from exceptional founders. By providing broad support across disciplines and longitudinal support through product development and company stages, our team relentlessly supports our founders. We seek to maximize their impact on patients. We work to make their light shine brighter.

For more information, please visit Bioluminescence.com.